Log In
Print
BCIQ
Print
Print this Print this
 

Leukotac, inolimomab

  Manage Alerts
Collapse Summary General Information
Company Jazz Pharmaceuticals plc
DescriptionAnti-CD25 mAb
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationGraft-versus-host disease (GvHD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today